Literature DB >> 33315146

[The ESC recommendations for COVID-19-no guideline, but a learning guidance].

Bernhard Maisch1,2,3.   

Abstract

"Not a guideline but a guidance" is the motto of this document of guidance by the European Society of Cardiology, which is designed as an orientation aid to learning for physicians in the coronavirus disease 2019 (COVID-19) pandemic. A total of 62 European cardiologists as authors and 29 further experts as reviewers have contributed to this 119-page document. The emphasis of the guidelines is on a cautious strategy in dealing with a pandemic, which is still characterized by many unknown factors. It is consciously limited to cardiovascular diseases. In the last update from 10 June 2020 many practical instructions for cardiovascular diagnostics and treatment under the conditions of a pandemic are given. These recommendations largely depend on the already well-known guidelines of the ESC. To recapitulate them might be helpful but much is redundant. The sections on the pathophysiology and pathomechanisms by which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could specifically affect the cardiovascular system, are informative but sometimes in need of supplementation. It is counterproductive to recommend that pathohistological and molecular investigations of tissues from affected and deceased patients should be avoided. This document of guidance is an ambitious attempt of a learning recommendation that needs some further improvement. It needs an early update if it intends to do justice to the ambitions.

Entities:  

Keywords:  Coronavirus; Heart diseases; Pandemic; Pathomechanisms; Protective measures

Year:  2020        PMID: 33315146     DOI: 10.1007/s00059-020-05006-x

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  17 in total

1.  Comprehensive diagnosis of septal myocardial infarction using optimized delayed enhancement cardiac computed tomography.

Authors:  Sophie Ribeyrolles; Adela Rohnean; Nicolas Amabile; Jean-François Paul
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-09-01       Impact factor: 6.875

2.  Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US.

Authors:  Katherine A Auger; Samir S Shah; Troy Richardson; David Hartley; Matthew Hall; Amanda Warniment; Kristen Timmons; Dianna Bosse; Sarah A Ferris; Patrick W Brady; Amanda C Schondelmeyer; Joanna E Thomson
Journal:  JAMA       Date:  2020-09-01       Impact factor: 56.272

3.  Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study.

Authors:  Daehoon Kim; Pil-Sung Yang; Jung-Hoon Sung; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Jong-Youn Kim; Hui-Nam Pak; Moon-Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  Eur Heart J       Date:  2020-12-14       Impact factor: 29.983

Review 4.  Cardio-Immunology of Myocarditis: Focus on Immune Mechanisms and Treatment Options.

Authors:  Bernhard Maisch
Journal:  Front Cardiovasc Med       Date:  2019-04-12

5.  SARS-CoV-2 as potential cause of cardiac inflammation and heart failure. Is it the virus, hyperinflammation, or MODS?

Authors:  Bernhard Maisch
Journal:  Herz       Date:  2020-06       Impact factor: 1.443

6.  Myocardial localization of coronavirus in COVID-19 cardiogenic shock.

Authors:  Guido Tavazzi; Carlo Pellegrini; Marco Maurelli; Mirko Belliato; Fabio Sciutti; Andrea Bottazzi; Paola Alessandra Sepe; Tullia Resasco; Rita Camporotondo; Raffaele Bruno; Fausto Baldanti; Stefania Paolucci; Stefano Pelenghi; Giorgio Antonio Iotti; Francesco Mojoli; Eloisa Arbustini
Journal:  Eur J Heart Fail       Date:  2020-04-11       Impact factor: 15.534

7.  STAR evidence evaluation of viral fulminant myocarditis: Specificity, Timeliness, Accessibility, Risk.

Authors:  Si Wang; Xin Wei; Hongde Hu
Journal:  Eur Heart J       Date:  2020-09-07       Impact factor: 29.983

8.  Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study.

Authors:  Carlo Mario Lombardi; Valentina Carubelli; Annamaria Iorio; Riccardo M Inciardi; Antonio Bellasi; Claudia Canale; Rita Camporotondo; Francesco Catagnano; Laura A Dalla Vecchia; Stefano Giovinazzo; Gloria Maccagni; Massimo Mapelli; Davide Margonato; Luca Monzo; Vincenzo Nuzzi; Chiara Oriecuia; Giulia Peveri; Andrea Pozzi; Giovanni Provenzale; Filippo Sarullo; Daniela Tomasoni; Pietro Ameri; Massimiliano Gnecchi; Sergio Leonardi; Marco Merlo; Piergiuseppe Agostoni; Stefano Carugo; Gian Battista Danzi; Marco Guazzi; Maria Teresa La Rovere; Andrea Mortara; Massimo Piepoli; Italo Porto; Gianfranco Sinagra; Maurizio Volterrani; Claudia Specchia; Marco Metra; Michele Senni
Journal:  JAMA Cardiol       Date:  2020-11-01       Impact factor: 14.676

9.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome.

Authors:  Zhe Xu; Lei Shi; Yijin Wang; Jiyuan Zhang; Lei Huang; Chao Zhang; Shuhong Liu; Peng Zhao; Hongxia Liu; Li Zhu; Yanhong Tai; Changqing Bai; Tingting Gao; Jinwen Song; Peng Xia; Jinghui Dong; Jingmin Zhao; Fu-Sheng Wang
Journal:  Lancet Respir Med       Date:  2020-02-18       Impact factor: 30.700

10.  SARS-CoV-2: a potential novel etiology of fulminant myocarditis.

Authors:  Chen Chen; Yiwu Zhou; Dao Wen Wang
Journal:  Herz       Date:  2020-05       Impact factor: 1.740

View more
  1 in total

1.  [2 years COVID-19 pandemic-What have we learned?]

Authors:  Bernhard Maisch; Rolf Dörr
Journal:  Herz       Date:  2022-03-21       Impact factor: 1.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.